Cart
sales@molnova.com
Ataciguat
CAS No. 254877-67-3
Ataciguat( HMR-1766 )
Catalog No. M27435 CAS No. 254877-67-3
Ataciguat (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 113 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 550 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtaciguat
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtaciguat (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator.
-
DescriptionAtaciguat (HMR-1766) is a potent and specific soluble guanylate cyclase (sGC) activator.(In Vitro):Ataciguat induces the relaxation in aortic rings or coronary rings. In the presence of nitric oxide synthase (NOS) inhibitor, the endothelium effect was abolished to DETA-NO or ataciguat, in both vessels. Ataciguat was able to induce NO production in HUVECs cells. In the presence of NOS inhibitor, the NO production induced by ataciguat was abolished.
-
In Vitro——
-
In Vivo——
-
SynonymsHMR-1766
-
PathwayOthers
-
TargetOther Targets
-
RecptorPGE|ATPase|Potassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number254877-67-3
-
Formula Weight576.48
-
Molecular FormulaC21H19Cl2N3O6S3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (173.46 mM)
-
SMILESClc1ccc(s1)S(=O)(=O)Nc1ccc(Cl)cc1C(=O)Nc1ccc(cc1)S(=O)(=O)N1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim DH, et al. Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity. Arch Pharm Res. 1999 Feb;22(1):30-4.
molnova catalog
related products
-
PGP-4008
PGP-4008 is a selective and potent P-glycoprotein (Pgp) inhibitor that inhibits tumor growth by co-administration with Doxorubicin.
-
Elamipretide 2TFA
Elamipretide is a novel mitochondrion-targeted antioxidant.?Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.
-
Methyl retinoate
Methyl retinoate (Retinoic acid, methyl ester) induces aseptic inflammation at the site of administration in in vivo experiments, which causes an increase in the number of leukocytes in the blood and a decrease in the levels of red blood cells and Hb.Methyl retinoate promotes spontaneous leukemia.Methyl retinoate can be Used in the treatment of gastric hypertrophy and ulcers due to vitamin A deficiency.
